Showing results (501-510 of 5,003) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|June 1, 1995
Cutaneous neuroendocrine (Merkel cell) carcinoma. A report of 35 casesD E Smith, S Bielamowicz, A R Kagan, et al.
American Journal of Clinical Oncology|June 1, 1995
Resistance to common viruses during intralymphatic injections of tumor cell vaccines. Correlation with circulating cytokinesG Juillard, D Padua, D Canlapan, et al.
American Journal of Clinical Oncology|June 1, 1995
Phase I-II study of vinblastine and oral cyclosporin A in metastatic renal cell carcinomaE Warner, S W Tobe, I L Andrulis, et al.
American Journal of Clinical Oncology|June 1, 1995
Adjuvant chemoimmunotherapy for hepatocellular carcinoma patients. Adriamycin, interleukin-2, and lymphokine-activated killer cells versus adriamycin aloneA Kawata, Y Une, M Hosokawa, et al.
American Journal of Clinical Oncology|June 1, 1995
Prolonged continuous infusion of carboplatin and concomitant radiotherapy in advanced head and neck cancer. A phase I studyG Ausili-Cèfaro, L Marmiroli, L Nardone, et al.
American Journal of Clinical Oncology|February 1, 1995
Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphomaJ R Carrión, F R García Arroyo, P Salinas
American Journal of Clinical Oncology|February 1, 1995
Lung cancer in patients with human immunodeficiency virus infectionM R Flores, K S Sridhar, R J Thurer, et al.
American Journal of Clinical Oncology|February 1, 1995
A phase II study of recombinant interferon-gamma following combination chemotherapy for patients with extensive small cell lung cancer. CALGBJ D Bitran, M Green, M Perry, et al.
American Journal of Clinical Oncology|December 1, 1982
Interstitial 252Cf neutron therapy for glioblastoma multiformeY Maruyama, H W Chin, A B Young, et al.
American Journal of Clinical Oncology|April 1, 1983
A randomized phase II study of m-AMSA (NSC 249992) and neocarzinostatin (NSC 157365) in non-small cell bronchogenic carcinoma. An Eastern Cooperative Group StudyD S Ettinger, R Day, J A Ferraro, et al.
Pageof 501